-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi plans to transfer 20 established drugs, 3 plants to Cheplapharm for 26.4% stake

PUBT·09/14/2026 13:58:43
Listen to the news
Sanofi plans to transfer 20 established drugs, 3 plants to Cheplapharm for 26.4% stake
  • Cheplapharm plans to acquire 20 established medicines from Sanofi, alongside three manufacturing sites, under a new strategic partnership.
  • Assets include plants in Csanyikvölgy, Hungary, Jurong, Singapore, and Ploërmel, France; portfolio transfer set to start in Q1 2027.
  • Full closing targeted for Q3 2027, subject to regulatory clearances and employee consultation processes.
  • Sanofi will take a 26.4% stake in Cheplapharm as part of the deal; assets include Lovenox/Clexane outside the US.
  • Sanofi expects no impact on its 2026 financial guidance from the planned transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cheplapharm AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2398918_de) on September 14, 2026, and is solely responsible for the information contained therein.